<DOC>
	<DOCNO>NCT01460446</DOCNO>
	<brief_summary>This clinical , prospective , randomize , multi-center study determine use insulin bolus advisor improve glycemic control measure change HbA1c patient fail multiple daily injection/intensified conventional therapy ( MDI/ICT ) .</brief_summary>
	<brief_title>ACCU-CHEK® Aviva Expert Study : Does Use Bolus Advisor Improve Glycemic Control Patients Not Achieving Optimal Control Using Multiple Daily Injections ( MDI ) ?</brief_title>
	<detailed_description>Eligible participant randomize 24 week multiple daily injection therapy use either Accu-Chek® Aviva Expert blood glucose meter integrate bolus advisor Accu-Chek® Aviva Nano blood glucose meter manual bolus calculation .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Must 18 year age old . Diagnosed Type 1 Type 2 diabetes . Recent HbA1c &gt; 7.5 % ( measure within last 6 week local laboratory ) . On multiple daily injection ( MDI ) therapy least 6 month consist 12 injection per day longacting basal insulin ( Lantus® Detemir® ) least 2 injection per day regular rapidacting analog insulin meal coverage . Subject adjusts meal insulin dos base carbohydrate content meal . Subject Type 2 diabetes may stable metformin therapy ( therapy unchanged 3 month prior study ) . Subject Investigator 's practice least 3 month may see another physician practice . Subject complete carbohydrate ( CHO ) training within last 2 year . Subject therapy regimen conflict study : Neutral protamine Hagedorn ( NPH ) premixed insulin ; oral antidiabetic agent , exception metformin ; injectable antidiabetic agent longacting insulin rapidacting insulin analog regular insulin ( eg , fix dose therapy ) ; use slide scale insulin therapy determine insulin dosage base exclusively specific blood glucose ( bG ) result . Subject participate another interventional trial within 6 week prior study . Subject diagnose clinically significant infectious disease major organ system disease , gastroparesis renal disease ( Investigator 's discretion ) . Subject used systemic oral inhale steroid 7 day within last 3 month . Subject chemotherapy radiation therapy ( selfreported ) . Subject pregnant lactate currently plan pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>